Benzinga | Aug 12, 2021 04:37PM EDT

Tempest Therapeutics Q2 EPS $(7.63) Up From $(11.42) YoY

Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(7.63) per share. This is a 33.19 percent increase over losses of $(11.42) per share from the same period last year.